News Johnson & Johnson reports net earnings of $5.3bn in Q1 2024 The company’s first quarter reported sales grew 2.3% to $21.4bn from $20.8bn in Q1 2023.
Data Insights Q4 2023 update: remote patient monitoring related M&A activity in the pharmaceutical industry
Data Insights Q4 2023 update: electronic medical record (emr) systems related M&A activity in the pharmaceutical industry
Data Insights Q3 2023 update: environmental sustainability related hiring actvity in the pharma industry
News Signal: Big Pharma embraces AI as Novo Nordisk partners with AI start-up Valo in $2.7bn deal Sarah Brady